Treatment Action Campaign v Rath and Others (2807/05) [2006] ZAWCHC 8; [2007] 2 All SA 439 (C); 2007 (4) SA 563 (C) (3 March 2006)
The court found that while robust public debate on the efficacy of anti-retroviral drugs is protected by freedom of expression, the respondents' specific allegations that the applicant is a front for pharmaceutical companies and is funded by them are defamatory and unsupported by evidence. The applicant demonstrated a prima facie right to protection of its reputation, and the harm caused by such statements could not be remedied by damages. The court held that the limited restraint on free speech imposed by the interim interdict is justified to prevent irreparable harm to the applicant's mission and reputation, without unduly restricting legitimate public debate. The balance of...
- Citation
- [2006] ZAWCHC 8
- Parties
- Applicant: Treatment Action Campaign; Respondent: Matthias Rath; Respondent: Dr Rath Health Foundations; Respondent: Traditional Healers Organisation
- Court
- Western Cape High Court, Cape Town
- Jurisdiction
- South Africa
- Judgment Date
- 3 March 2006
- Case Number
- 2807/05
- Procedural Posture
- Urgent Application / Interim Interdict Application Prior to Trial
- Outcome
- Interim interdict granted restraining respondents from publishing specified defamatory statements pending final determination of the main action.
- Judges
- Desai, Louw, Moosa
- Legal Topics
- Freedom of Expression, Defamation, Interim Interdict, Balancing of Rights, Human Dignity
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Treatment Action Campaign
Applicant
Matthias Rath
Respondent
Dr Rath Health Foundations
Respondent
Traditional Healers Organisation
Respondent
Procedural Posture
Urgent Application / Interim Interdict Application Prior to Trial
Legal Issues
- 1 Whether the respondents' statements alleging that the applicant is a front for pharmaceutical companies are defamatory.
- 2 Whether the applicant is entitled to an interim interdict restraining publication of such statements pending trial.
- 3 How to balance the constitutional rights to freedom of expression and dignity/reputation in the context of public debate on HIV/AIDS.
Ratio Decidendi
The court found that while robust public debate on the efficacy of anti-retroviral drugs is protected by freedom of expression, the respondents' specific allegations that the applicant is a front for pharmaceutical companies and is funded by them are defamatory and unsupported by evidence. The applicant demonstrated a prima facie right to protection of its reputation, and the harm caused by such statements could not be remedied by damages. The court held that the limited restraint on free speech imposed by the interim interdict is justified to prevent irreparable harm to the applicant's mission and reputation, without unduly restricting legitimate public debate. The balance of...
Court Disposition
Interim interdict granted restraining respondents from publishing specified defamatory statements pending final determination of the main action.
Orders
- The respondents are interdicted, pending the final determination of an action instituted by the applicant, from publishing any statement alleging that the applicant is a front for pharmaceutical companies or the pharmaceutical industry, or the 'Trojan horse' or 'running dog' of that industry.
- The respondents are interdicted from publishing any statement alleging that the applicant is funded by pharmaceutical companies or the pharmaceutical industry.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment